Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT06640010
Status
Recruiting
Apply to this trial

Conditions

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.

Key Dates

First listed
Oct 15, 2024
Start date
Feb 12, 2025
Status verified
Jun 2026
Primary completion
Dec 15, 2027
Completion
Dec 15, 2027

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Observational
    Patients undergo blood sample collection and have their medical records reviewed on study.

Primary Outcome Measure

In vitro measurement of cellular viability in response to chemotherapy [ Time Frame: Blood drawn at enrollment to obtain sample ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in FloridaJacksonvilleFlorida32224-9980
Clinical Trials Referral Office
[email protected]
855-776-0015
Nadine Norton, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Jacksonville, FL

By research site
Mayo Clinic in Florida· Jacksonville, FL

Related Studies